Insight

Anne Knisely: Metronidazole and Cefazolin for SSI prophylaxis in gynaecological surgery

Photo taken from Anne Knisely/LinkedIn

Aug 27, 2024, 02:59

Anne Knisely: Metronidazole and Cefazolin for SSI prophylaxis in gynaecological surgery

Anne Knisely, Gynaecology and Oncology fellow at MD Anderson Cancer Center, shared a post by AJOG on X, adding:

“Excited to share our QI paper published in AJOG. If you’re not already adding metronidazole to cefazolin for SSI prophylaxis in gynaecological surgery, you should start!

Adjusted OR for SSI 0.49 decrease with addition of metronidazole.”

Quoting AJOG’s post:

“Metronidazole and cefazolin vs cefazolin alone for surgical site infection prophylaxis in gynecologic surgery at a comprehensive cancer center.”

Source: Anne Knisely/X and AJOG/X

Metronidazole and cefazolin vs cefazolin alone for surgical site infection prophylaxis in gynecologic surgery at a comprehensive cancer center.

Authors: Anne Knisely, Maria D. Iniesta, Claire A. Marten, Gary Chisholm, Kathleen M. Schmeler, and Jolyn S. Taylor.

Anne Knisely

AJOG Anne Knisely cancer cefazolin Claire A. Marten Gary Chisholm gynecologic surgery Jolyn S. Taylor Kathleen M. Schmeler Maria D. Iniesta Metronidazole OncoDaily Oncology SSI prophylaxis

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

Arnaud Lallouette: Servier and IDEAYA Partner to Bring a Promising Uveal Melanoma Treatment

100 Oncologists, One Community: Reflections from the First ESO College Convention

Gevorg Tamamyan: "Fertility News" is on the Way

JCO on a Jamaican Beach: The Journey of Joyson Karakunnel